Artykuły w czasopismach na temat „MET/HGF”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „MET/HGF”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Toiyama, Y., K. Tanaka, H. Yasuda, S. Saigusa, H. Fujikawa, Y. Mohri, Y. Inoue, C. Miki, T. Tabata i M. Kusunoki. "Use of co-expression of HGF and c-Met to predict peritoneal dissemination established by autocrine HGF/c-Met signaling in gastric cancer." Journal of Clinical Oncology 29, nr 4_suppl (1.02.2011): 40. http://dx.doi.org/10.1200/jco.2011.29.4_suppl.40.
Pełny tekst źródłaZhang, Hongli, Qingqing Feng, Wei-Dong Chen i Yan-Dong Wang. "HGF/c-MET: A Promising Therapeutic Target in the Digestive System Cancers". International Journal of Molecular Sciences 19, nr 11 (23.10.2018): 3295. http://dx.doi.org/10.3390/ijms19113295.
Pełny tekst źródłaWeimar, Iris S., Daphne de Jong, Egbert J. Muller, Toshikazu Nakamura, Joost M.H.H. van Gorp, Gijsbert C. de Gast i Winald R. Gerritsen. "Hepatocyte Growth Factor/Scatter Factor Promotes Adhesion of Lymphoma Cells to Extracellular Matrix Molecules Via α4β1 and α5β1 Integrins". Blood 89, nr 3 (1.02.1997): 990–1000. http://dx.doi.org/10.1182/blood.v89.3.990.
Pełny tekst źródłaGallo, Simona, Valentina Sala, Stefano Gatti i Tiziana Crepaldi. "Cellular and molecular mechanisms of HGF/Met in the cardiovascular system". Clinical Science 129, nr 12 (11.11.2015): 1173–93. http://dx.doi.org/10.1042/cs20150502.
Pełny tekst źródłaDe Silva, Dinuka M., Arpita Roy, Takashi Kato, Fabiola Cecchi, Young H. Lee, Kunio Matsumoto i Donald P. Bottaro. "Targeting the hepatocyte growth factor/Met pathway in cancer". Biochemical Society Transactions 45, nr 4 (3.07.2017): 855–70. http://dx.doi.org/10.1042/bst20160132.
Pełny tekst źródłaKauma, Scott, Natalie Hayes i Shannon Weatherford. "The Differential Expression of Hepatocyte Growth Factor and Met in Human Placenta*". Journal of Clinical Endocrinology & Metabolism 82, nr 3 (1.03.1997): 949–54. http://dx.doi.org/10.1210/jcem.82.3.3806.
Pełny tekst źródłaYamasaki, Koji, Shoichiro Mukai, Takahiro Nagai, Kozue Nakahara, Masato Fujii, Naoki Terada, Akinobu Ohno i in. "Matriptase-Induced Phosphorylation of MET is Significantly Associated with Poor Prognosis in Invasive Bladder Cancer; an Immunohistochemical Analysis". International Journal of Molecular Sciences 19, nr 12 (22.11.2018): 3708. http://dx.doi.org/10.3390/ijms19123708.
Pełny tekst źródłaWoolf, A. S., M. Kolatsi-Joannou, P. Hardman, E. Andermarcher, C. Moorby, L. G. Fine, P. S. Jat, M. D. Noble i E. Gherardi. "Roles of hepatocyte growth factor/scatter factor and the met receptor in the early development of the metanephros." Journal of Cell Biology 128, nr 1 (1.01.1995): 171–84. http://dx.doi.org/10.1083/jcb.128.1.171.
Pełny tekst źródłaTanaka, Ryota, Mizue Terai, Eric Londin i Takami Sato. "The Role of HGF/MET Signaling in Metastatic Uveal Melanoma". Cancers 13, nr 21 (30.10.2021): 5457. http://dx.doi.org/10.3390/cancers13215457.
Pełny tekst źródłaCzyz, Malgorzata. "HGF/c-MET Signaling in Melanocytes and Melanoma". International Journal of Molecular Sciences 19, nr 12 (3.12.2018): 3844. http://dx.doi.org/10.3390/ijms19123844.
Pełny tekst źródłaKumar, Vinod, Zachary A. Yochum, Princey Devadassan, Eric Huang, Ethan Miller, Vasavi Ayyala, Laura P. Stabile, Timothy F. Burns i Purva H. Rumde. "Abstract 1091: TWIST1 inhibition overcomes resistance to tyrosine kinase inhibitors in MET driven non-small cell lung cancer". Cancer Research 82, nr 12_Supplement (15.06.2022): 1091. http://dx.doi.org/10.1158/1538-7445.am2022-1091.
Pełny tekst źródłaSato, Hiroki, Ryu Imamura, Hiroaki Suga, Kunio Matsumoto i Katsuya Sakai. "Cyclic Peptide-Based Biologics Regulating HGF-MET". International Journal of Molecular Sciences 21, nr 21 (27.10.2020): 7977. http://dx.doi.org/10.3390/ijms21217977.
Pełny tekst źródłaKentsis, Alex, Takaomi Sanda, Vu Ngo, Scott J. Rodig, Jeffery Kutok, Eleni Tholouli, Richard Byers i in. "Aberrant Expression of Hepatocyte Growth Factor Induces Autocrine MET Activation Providing a Novel Therapeutic Target In Acute Myeloid Leukemia." Blood 116, nr 21 (19.11.2010): 1042. http://dx.doi.org/10.1182/blood.v116.21.1042.1042.
Pełny tekst źródłaMcInnis, Ian, Theresa Hahn, Anasitasia Ioane, Ashleigh Lamson, Deepika Lal, Laurie Ann Ford, Sheila NJ Sait i in. "Diverse Roles of Hepatocyte Growth Factor (HGF) in Normal Karyotype Acute Myeloid Leukemia (AML)." Blood 114, nr 22 (20.11.2009): 3107. http://dx.doi.org/10.1182/blood.v114.22.3107.3107.
Pełny tekst źródłaZhou, Si-Rui, Wen-Ting Yuan, Xiao-Yan Pan, Tong Wang i Xiao-Dong Chen. "Hepatocyte growth factor promotes retinal pigment epithelium cell activity through MET/AKT signaling pathway". International Journal of Ophthalmology 17, nr 5 (18.05.2024): 806–14. http://dx.doi.org/10.18240/ijo.2024.05.03.
Pełny tekst źródłaBorset, M., H. Hjorth-Hansen, C. Seidel, A. Sundan i A. Waage. "Hepatocyte growth factor and its receptor c-met in multiple myeloma". Blood 88, nr 10 (15.11.1996): 3998–4004. http://dx.doi.org/10.1182/blood.v88.10.3998.bloodjournal88103998.
Pełny tekst źródłaAnastasi, Sergio, Silvia Giordano, Olga Sthandier, Giovanna Gambarotta, Rossella Maione, Paolo Comoglio i Paolo Amati. "A Natural Hepatocyte Growth Factor/Scatter Factor Autocrine Loop in Myoblast Cells and the Effect of the Constitutive Met Kinase Activation on Myogenic Differentiation". Journal of Cell Biology 137, nr 5 (2.06.1997): 1057–68. http://dx.doi.org/10.1083/jcb.137.5.1057.
Pełny tekst źródłaTahira, Yumiko, Katsuya Sakai, Hiroki Sato, Ryu Imamura i Kunio Matsumoto. "Dimer Interface in Natural Variant NK1 Is Dispensable for HGF-Dependent Met Receptor Activation". International Journal of Molecular Sciences 22, nr 17 (26.08.2021): 9240. http://dx.doi.org/10.3390/ijms22179240.
Pełny tekst źródłaChang, Chih-Ching, Jia-Jhen Chiu, Shan-Ling Chen, Hui-Chun Huang, Hui-Fen Chiu, Bo-Huei Lin i Chun-Yuh Yang. "Activation of HGF/c-Met signaling by ultrafine carbon particles and its contribution to alveolar type II cell proliferation". American Journal of Physiology-Lung Cellular and Molecular Physiology 302, nr 8 (15.04.2012): L755—L763. http://dx.doi.org/10.1152/ajplung.00350.2011.
Pełny tekst źródłaDedov, I. I., Ye A. Troshina, N. V. Mazurina i A. Belfiore. "Low expression of Met-hepatocytic growth factor receptor as an indicator of poor prognosis in thyroid tumors". Problems of Endocrinology 47, nr 3 (15.06.2001): 6–10. http://dx.doi.org/10.14341/probl11467.
Pełny tekst źródłaYou, Jingjing, Li Wen, Athena Roufas, Chris Hodge, Gerard Sutton i Michele C. Madigan. "Expression of HGF and c-Met Proteins in Human Keratoconus Corneas". Journal of Ophthalmology 2015 (2015): 1–8. http://dx.doi.org/10.1155/2015/852986.
Pełny tekst źródłaBlanquaert, Frederic, Renata C. Pereira i Ernesto Canalis. "Cortisol inhibits hepatocyte growth factor/scatter factor expression and induces c-met transcripts in osteoblasts". American Journal of Physiology-Endocrinology and Metabolism 278, nr 3 (1.03.2000): E509—E515. http://dx.doi.org/10.1152/ajpendo.2000.278.3.e509.
Pełny tekst źródłaBoschert, Verena, Nicola Klenk, Alexander Abt, Sudha Janaki Raman, Markus Fischer, Roman C. Brands, Axel Seher i in. "The Influence of Met Receptor Level on HGF-Induced Glycolytic Reprogramming in Head and Neck Squamous Cell Carcinoma". International Journal of Molecular Sciences 21, nr 2 (11.01.2020): 471. http://dx.doi.org/10.3390/ijms21020471.
Pełny tekst źródłaCao, Tong, Jing Pan, Xiulian Li, Yanli He, Yifei Jiang, Yajing Chang, Qi Zhang i in. "Isolation and Characterization of a Chinese Hamster Ovary Heparan Sulfate Cell Mutant Defective in Both Met Receptor Binding and Hepatocyte Growth Factor NK1/Met Signaling". Cellular Physiology and Biochemistry 48, nr 4 (2018): 1480–91. http://dx.doi.org/10.1159/000492258.
Pełny tekst źródłaBeilmann, Mario, George F. Vande Woude, Hans-Peter Dienes i Peter Schirmacher. "Hepatocyte growth factor–stimulated invasiveness of monocytes". Blood 95, nr 12 (15.06.2000): 3964–69. http://dx.doi.org/10.1182/blood.v95.12.3964.
Pełny tekst źródłaBeilmann, Mario, George F. Vande Woude, Hans-Peter Dienes i Peter Schirmacher. "Hepatocyte growth factor–stimulated invasiveness of monocytes". Blood 95, nr 12 (15.06.2000): 3964–69. http://dx.doi.org/10.1182/blood.v95.12.3964.012k20_3964_3969.
Pełny tekst źródłaHay, Rick V., Brian Cao, R. Scot Skinner, Ling-Mei Wang, Yanli Su, James H. Resau, George F. Vande Woude i Milton D. Gross. "Radioimmunoscintigraphy of Tumors Autocrine for Human Met and Hepatocyte Growth Factor/Scatter Factor". Molecular Imaging 1, nr 1 (1.01.2002): 153535002002000. http://dx.doi.org/10.1162/15353500200200006.
Pełny tekst źródłaTonomura, Hitoshi, Masateru Nagae, Ryota Takatori, Hidenobu Ishibashi, Tomonori Itsuji i Kenji Takahashi. "The Potential Role of Hepatocyte Growth Factor in Degenerative Disorders of the Synovial Joint and Spine". International Journal of Molecular Sciences 21, nr 22 (18.11.2020): 8717. http://dx.doi.org/10.3390/ijms21228717.
Pełny tekst źródłaXu, Chuanhui, Anke Van Den Berg, Wouter Plattel, Nele Ruther, Huang Xin, Miao Wang, Gustaaf Van Imhoff i in. "Expression of the c-Met Oncogene Correlates with Favorable Progression Free Survival In Classical Hodgkin Lymphoma". Blood 116, nr 21 (19.11.2010): 3880. http://dx.doi.org/10.1182/blood.v116.21.3880.3880.
Pełny tekst źródłaSweis, Randy F., Petros Grivas, Alexander T. Pearson, Kathleen C. Day, Mark L. Day i Maha Hussain. "Expression of MET and HGF in bladder cancer tumorigenesis and invasion." Journal of Clinical Oncology 30, nr 15_suppl (20.05.2012): 4573. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.4573.
Pełny tekst źródłaBeilmann, Mario, Margarete Odenthal, Waltraud Jung, George F. Vande Woude, Hans-Peter Dienes i Peter Schirmacher. "Neoexpression of the c-met/Hepatocyte Growth Factor-Scatter Factor Receptor Gene in Activated Monocytes". Blood 90, nr 11 (1.12.1997): 4450–58. http://dx.doi.org/10.1182/blood.v90.11.4450.
Pełny tekst źródłaBeilmann, Mario, Margarete Odenthal, Waltraud Jung, George F. Vande Woude, Hans-Peter Dienes i Peter Schirmacher. "Neoexpression of the c-met/Hepatocyte Growth Factor-Scatter Factor Receptor Gene in Activated Monocytes". Blood 90, nr 11 (1.12.1997): 4450–58. http://dx.doi.org/10.1182/blood.v90.11.4450.4450_4450_4458.
Pełny tekst źródłaTjin, Esther P. M., Richard W. J. Groen, Irma Vogelzang, Patrick W. B. Derksen, Melanie D. Klok, Helen P. Meijer, Susanne van Eeden, Steven T. Pals i Marcel Spaargaren. "Functional analysis of HGF/MET signaling and aberrant HGF-activator expression in diffuse large B-cell lymphoma". Blood 107, nr 2 (15.01.2006): 760–68. http://dx.doi.org/10.1182/blood-2005-05-1929.
Pełny tekst źródłaSierra, J. Rafael, i Ming-Sound Tsao. "c-MET as a potential therapeutic target and biomarker in cancer". Therapeutic Advances in Medical Oncology 3, nr 1_suppl (listopad 2011): S21—S35. http://dx.doi.org/10.1177/1758834011422557.
Pełny tekst źródłaBorset, Magne, Hakon Hov, Randi U. Holt, Torstein B. Ro, Unn-Merete Fagerli, Henrik Hjorth-Hansen, Vadim Baykov, James G. Christensen, Anders Waage i Anders Sundan. "A Selective Inhibitor of c-Met Blocks an Autocrine HGF Growth Loop in ANBL-6 Cells and Prevents Migration and Adhesion of Myeloma Cells." Blood 104, nr 11 (16.11.2004): 2358. http://dx.doi.org/10.1182/blood.v104.11.2358.2358.
Pełny tekst źródłaCerqua, Marina, Orsola Botti, Maddalena Arigoni, Noemi Gioelli, Guido Serini, Raffaele Calogero, Carla Boccaccio, Paolo M. Comoglio i Dogus M. Altintas. "MET∆14 promotes a ligand-dependent, AKT-driven invasive growth". Life Science Alliance 5, nr 10 (30.05.2022): e202201409. http://dx.doi.org/10.26508/lsa.202201409.
Pełny tekst źródłaUzumcu, Mehmet, Zui Pan, Yi Chu, Peter E. Kuhn i Rob Zachow. "Immunolocalization of the hepatocyte growth factor (HGF) system in the rat ovary and the anti-apoptotic effect of HGF in rat ovarian granulosa cells in vitro". Reproduction 132, nr 2 (sierpień 2006): 291–99. http://dx.doi.org/10.1530/rep.1.00989.
Pełny tekst źródłaMiranda, Oshin, Mariya Farooqui i Jill Siegfried. "Status of Agents Targeting the HGF/c-Met Axis in Lung Cancer". Cancers 10, nr 9 (21.08.2018): 280. http://dx.doi.org/10.3390/cancers10090280.
Pełny tekst źródłaKempe, Sabrina. "MET-Inhibitoren sperren Ausweichroute über HGF/c-MET-Signalweg". Im Fokus Onkologie 25, nr 2 (kwiecień 2022): 29–33. http://dx.doi.org/10.1007/s15015-022-3829-8.
Pełny tekst źródłaRicci, G., A. Catizone i M. Galdieri. "Expression and functional role of hepatocyte growth factor and its receptor (c-met) during fetal mouse testis development". Journal of Endocrinology 191, nr 3 (grudzień 2006): 559–70. http://dx.doi.org/10.1677/joe.1.06879.
Pełny tekst źródłaBuchynska, L. G., O. V. Brieieva i S. V. Nespriadko. "EXPRESSION OF HEPATOCYTE GROWTH FACTOR AND C-MET RECEPTOR IN STROMAL FIBROBLASTS AND TUMOR CELLS OF ENDOMETRIAL CARCINOMA". Experimental Oncology 45, nr 1 (2023): 79–87. http://dx.doi.org/10.15407/exp-oncology.2023.01.079.
Pełny tekst źródłaXu, Chuanhui, Anke Van Den Berg, Arjan Diepstra, Miao Wang, Debora Jong, Hans JTWM Vos, Peter Moller, Sibrand Poppema i Lydia Visser. "The HGF/c-Met Signaling Pathway in Hodgkin Lymphoma." Blood 114, nr 22 (20.11.2009): 1551. http://dx.doi.org/10.1182/blood.v114.22.1551.1551.
Pełny tekst źródłaElliott, Bruce E., Wesley L. Hung, Alexander H. Boag i Alan B. Tuck. "The role of hepatocyte growth factor (scatter factor) in epithelialmesenchymal transition and breast cancer". Canadian Journal of Physiology and Pharmacology 80, nr 2 (1.02.2002): 91–102. http://dx.doi.org/10.1139/y02-010.
Pełny tekst źródłaTsubaki, Masanobu, Shiori Seki, Tomoya Takeda, Akiko Chihara, Yuuko Arai, Yuusuke Morii, Motohiro Imano, Takao Satou, Kazunori Shimomura i Shozo Nishida. "The HGF/Met/NF-κB Pathway Regulates RANKL Expression in Osteoblasts and Bone Marrow Stromal Cells". International Journal of Molecular Sciences 21, nr 21 (24.10.2020): 7905. http://dx.doi.org/10.3390/ijms21217905.
Pełny tekst źródłaChattopadhyay, Naibedya, R. J. MacLeod, Jacob Tfelt-Hansen i Edward M. Brown. "1α,25(OH)2-vitamin D3inhibits HGF synthesis and secretion from MG-63 human osteosarcoma cells". American Journal of Physiology-Endocrinology and Metabolism 284, nr 1 (1.01.2003): E219—E227. http://dx.doi.org/10.1152/ajpendo.00247.2002.
Pełny tekst źródłaUMITSU, Masataka, i Junichi TAKAGI. "Structural basis of HGF-Met signaling". Japanese Journal of Thrombosis and Hemostasis 27, nr 1 (2016): 77–84. http://dx.doi.org/10.2491/jjsth.27.77.
Pełny tekst źródłaZhou, Hong, Yuen Pon i Alice Wong. "HGF/MET Signaling in Ovarian Cancer". Current Molecular Medicine 8, nr 6 (1.09.2008): 469–80. http://dx.doi.org/10.2174/156652408785747933.
Pełny tekst źródłaJalili, Ali, Neeta Shirvaikar, Sara Ilnitsky, A. Robert Turner, Mariusz Z. Ratajczak i Anna Janowska-Wieczorek. "G-CSF Induces Expression of Both Hepatocyte Growth Factor (HGF) and Its Receptor (c-Met) in Human Hematopoietic Stem/Progenitor Cells and Mature Myeloid Cells - Novel Evidence That during Mobilization the HGF-c-Met Axis Counterbalances G-CSF-Induced Attenuation of the SDF-1-CXCR4 Axis." Blood 110, nr 11 (16.11.2007): 2203. http://dx.doi.org/10.1182/blood.v110.11.2203.2203.
Pełny tekst źródłaLiu, Y., E. M. Tolbert, A. M. Sun i L. D. Dworkin. "Primary structure of rat HGF receptor and induced expression in glomerular mesangial cells". American Journal of Physiology-Renal Physiology 271, nr 3 (1.09.1996): F679—F688. http://dx.doi.org/10.1152/ajprenal.1996.271.3.f679.
Pełny tekst źródłaZachow, Rob, i Mehmet Uzumcu. "The hepatocyte growth factor system as a regulator of female and male gonadal function". Journal of Endocrinology 195, nr 3 (13.09.2007): 359–71. http://dx.doi.org/10.1677/joe-07-0466.
Pełny tekst źródła